UiPath (PATH)
(Delayed Data from NYSE)
$12.00 USD
-0.25 (-2.04%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $11.98 -0.02 (-0.17%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth C Momentum B VGM
View All Zacks #1 Ranked Stocks
Brokerage Reports
0 items in cart
UiPath, Inc. [PATH]
Reports for Purchase
Showing records 61 - 80 ( 129 total )
Company: UiPath, Inc.
Industry: Technology Services
Price: 25.00
Company: UiPath, Inc.
Industry: Technology Services
Price: 10.00
Company: UiPath, Inc.
Industry: Technology Services
Initiating RPA & Enterprise Automation Leader at OW
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Price: 150.00
Company: UiPath, Inc.
Industry: Medical - Products
Price: 10.00
Company: UiPath, Inc.
Industry: Medical - Products
February and 2014 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: UiPath, Inc.
Industry: Medical - Products
February and 2014 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: UiPath, Inc.
Industry: Medical - Products
Downgrading to NEUTRAL and Reducing Our FV to $5 as PATH is Likely to Trade In line with TEVA- TEVA Looks to be the Winner
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: UiPath, Inc.
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events for the Week of Dec. 9
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: UiPath, Inc.
Industry: Medical - Products
December 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: UiPath, Inc.
Industry: Medical - Products
December 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: UiPath, Inc.
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov. 25
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: UiPath, Inc.
Industry: Medical - Products
Q3 Financials: Cash Runway Through Jan. 2014; Awaiting Potential Partnership(s) as Launch Delayed Until After Yearend; Reiterate OUTPERFORM and $8 FV
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 25.00
Company: UiPath, Inc.
Industry: Medical - Products
November and Remaining 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: UiPath, Inc.
Industry: Medical - Products
November and Remaining 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: UiPath, Inc.
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events for the Week of Oct. 28
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: UiPath, Inc.
Industry: Medical - Products
The Week Ahead in Life Sciences - Upcoming Events
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: UiPath, Inc.
Industry: Medical - Products
Initiation of Adolescent Migraineurs Phase 1 is Part of FDA Post-marketing Requirements
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 25.00
Company: UiPath, Inc.
Industry: Medical - Products
Additional US Patent Allowance For Zecuity Further Strengthens Intellectual Property; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 25.00
Company: UiPath, Inc.
Industry: Medical - Products
Emerging Pharmaceuticals - September and Remaining 2013 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: UiPath, Inc.
Industry: Medical - Products
Q2 Financials: Runway Guidance Into Q4 Reiterated; Next: Potential Partnership(s) And Q4 Launch; Reiterate OUTPERFORM And $8 FV
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 25.00